Arcutis Historical Income Statement
| ARQT Stock | USD 11.71 0.20 1.74% |
Historical analysis of Arcutis Biotherapeutics income statement accounts such as Selling General Administrative of 182.2 M, Total Revenue of 62.6 M or Other Operating Expenses of 159.7 M can show how well Arcutis Biotherapeutics performed in making a profits. Evaluating Arcutis Biotherapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Arcutis Biotherapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Arcutis Biotherapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arcutis Biotherapeutics is a good buy for the upcoming year.
Arcutis |
About Arcutis Income Statement Analysis
Arcutis Biotherapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Arcutis Biotherapeutics shareholders. The income statement also shows Arcutis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Arcutis Biotherapeutics Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Arcutis Biotherapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Arcutis Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcutis Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.At this time, Arcutis Biotherapeutics' Interest Expense is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 182.2 M in 2024, despite the fact that Net Loss is likely to grow to (254.5 M).
Arcutis Biotherapeutics income statement Correlations
Click cells to compare fundamentals
Arcutis Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.